ST NYSE Week ended 24 Jul 2026

Weekly Investor Report

Sensata Technologies Holding NV · Technology · Scientific & Technical Instruments

Open interactive chart View report data
Latest close 45.71 USD
1.5% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 12.0% above the Trend Line and sits at 68.4% of its 52-week range. The latest completed week returned 1.5%, after a -2.4% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 56/100 conviction, while the latest news-sentiment score is 57/100. Near-term considerations: volume confirmation is below normal; earnings are due in 3d.

Setup score 63 out of 100
Latest Close 45.71 USD 24 Jul 2026
1W Return 1.5% latest completed week
4W Return -2.4% short-term follow-through
12W Return 8.6% quarterly tape
Trend Breadth 100.0% 52 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • The trend backdrop is active with a 55-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Next-week expectancy is positive at 57.15% based on similar historical setup states.
What could go wrong
  • Activity pressure is negative, which weakens the current setup.
  • 2 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 1.5% Latest completed week; four-week move -2.4%. Indicator stack 100/33 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 57.15% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Volatility 56/100 conviction; expected move 11.2%. News sentiment 57/100 41 relevant articles in the latest sentiment read. Event risk 3d Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 12.0% above the Trend Line and sits at 68.4% of its 52-week range. The latest completed week returned 1.5%, after a -2.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9212-week average 0.89

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.92Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -2.4% over four weeks, 8.6% over 12 weeks, and 41.4% over one year. The current trend has remained active for 55 consecutive weeks.

Performance by holding period

1W1.5%
4W-2.4%
12W8.6%
26W33.4%
52W41.4%
Active trend streak55 weeks
Active weeks in one year52
Trend breadth100.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.36Latest activity-pressure read.
Pressure change-128.2%Four-week change in activity pressure.
Leadership15.71Latest relative-leadership reading.
RS change-28.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength43/100Blend of value, momentum, and quality. Underlying universe rank 58; rank 1 is best.
Value34/100Relative valuation strength. Underlying universe rank 67; rank 1 is best.
Quality35/100Profitability and accounting quality. Underlying universe rank 66; rank 1 is best.
Momentum83/100Medium-term price momentum. Underlying universe rank 18; rank 1 is best.
Growth1/100Revenue and earnings growth. Underlying universe rank 100; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework62/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
137.2x
Price divided by trailing earnings.
Price / sales
1.8x
Market value relative to trailing revenue.
EV / EBITDA
11.5x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
8.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
28.0%
Gross profit retained from each unit of revenue.
Operating margin
14.1%
Operating profit retained from revenue.
Free-cash-flow margin
19.9%
Free cash flow generated from revenue.
Return on invested capital
3.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-3.0%
Latest one-year revenue growth.
EPS growth
-60.4%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
5.4%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.1%
Cash dividends relative to market value.
Buyback yield
0.7%
Net share repurchases relative to market value.
Shareholder yield
1.7%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

ST shows volatility options pressure with a 56/100 conviction score, put-call volume ratio of 0.03, expected move of 11.2%, and Sharemaestro trend signal active.

Conviction56/100
Expected move11.2%
Put/call volume0.03
Pressure100
Speculation28
Volatility76
Trend agreement0
Open options detail
Insider activity6 / 14

6 acquisitions and 14 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment57/100

Weighted news tone is neutral across 41 relevant articles.

16 positive · 25 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings3dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move11.2%Nearest-chain priced movement where available.
52-week drawdown-15.2%Distance below the 52-week high.
13-week volatility3.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher18 of 268 weeks finished lower.
Best week+12.5%Week of 10 Apr.
Worst week-11.7%Week of 6 Mar.
Latest week+1.5%Week of 24 Jul.

Shape of recent returns

Strong gains6
Modest gains12
Flat weeks0
Modest losses6
Sharp losses2
Recent vol3.7%13-week weekly-return volatility.
Base vol4.4%52-week weekly-return volatility.
Up/down split30/22Count of positive and negative weeks in the 52-week window.
Average skew3.6% / -3.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape68/100

Trend, activity pressure, participation, and risk combine to a 68/100 tape read.

 Indicator analysis84/100

Latest 12-week confirmation: trend 12/12, activity pressure 11/12, relative leadership 12/12.

Activity pressure 0.92; 2 reversal markers Next-Week ExpectancyPositive 57.15%

Next-week expectancy is positive with a 57.15% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors47/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 33; Small Cap Core rank 72 SVQF62/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 380.5 of 1013 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options36/100

ST shows volatility options pressure with a 56/100 conviction score, put-call volume ratio of 0.03, expected move of 11.2%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 11.2% Sentiment57/100

Weighted news tone is neutral across 41 relevant articles.

Sensata Technologies Holding PLC (ST) Stock Down 3.5% but Still Overvalued -- GF Score: 76/100 Insiders6 / 14

6 acquisitions and 14 disposals in the latest 180-day insider tape.

 Earnings3d

Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202645.71 USD1.5%40.82 USD33.86 USD-0.3615.717.1MOn
17 Jul 202645.05 USD-0.6%40.41 USD33.82 USD0.0113.817.4MOn
10 Jul 202645.32 USD-0.0%40.04 USD33.82 USD0.4213.157.1MOn
3 Jul 202645.34 USD-3.2%39.68 USD33.81 USD0.8615.117.9MOn
26 Jun 202646.85 USD-7.5%39.28 USD33.79 USD1.2621.949.6MOn
19 Jun 202650.63 USD0.5%38.78 USD33.77 USD1.4929.386.8MOn
12 Jun 202650.40 USD1.1%38.09 USD33.71 USD1.5830.9711.4MOn
5 Jun 202649.84 USD0.9%37.41 USD33.66 USD1.6231.3213.5MOn
29 May 202649.39 USD1.6%36.77 USD33.61 USD1.5227.9612.7MOn
22 May 202648.59 USD0.2%36.18 USD33.56 USD1.4628.7410.4MOn
15 May 202648.50 USD8.2%35.61 USD33.51 USD1.3830.7114.0MOn
8 May 202644.82 USD6.5%35.02 USD33.45 USD1.1121.9710.1MOn
1 May 202642.09 USD1.2%34.49 USD33.41 USD0.8117.9514.4MOn
24 Apr 202641.59 USD2.5%34.11 USD33.39 USD0.2518.5511.3MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.